Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator.
D000328:Adult; D000792:Angiography; D002986:Clinical Trials as Topic; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000378:metabolism; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D011669:Pulmonary Wedge Pressure; D011994:Recombinant Proteins / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use*
D005338:Fibrin Fibrinogen Degradation Products; D011994:Recombinant Proteins; D005340:Fibrinogen; D006493:Heparin; D010959:Tissue Plasminogen Activator